|
|
Post by mymann on Mar 4, 2021 20:11:09 GMT -5
Ok, simple math. Docs or mid level providers charge $300 and providers get $100. The Vedx gets rest. 10 patients equals $2000/day. Paying for overhead leaves ? FOR Profit.
|
|
|
|
Post by sportsrancho on Mar 4, 2021 20:13:47 GMT -5
Thank you nylefty..
Right, people come to us for blood sugar control and we put them on the best program for them. Some people come for Afrezza specifically, especially with the telemedicine. Others are referred by other doctors or hospitals or they see our advertisements around town or on Facebook locally.
Some have neuropathy or all kinds of different side effects from diabetes and they need guidance ,,they need someone that’s going to keep them accountable and hold their hand and change their life.
They come in every week for their session and they get one on one personal attention for 45 minutes to an hour. They learn how to use a CGM, they learn about diet and ultimately we teach them how to properly dose Afrezza.
Eventually we take the training wheels off and you’ve got an Afrezza user for life because believe me nothing compares!!
We hire our own doctors. And train them on how to prescribe and dose Afrezza. Which is quite a bit different than their own Endo would do going by Mannkind‘s dosing instructions.
|
|
|
|
Post by sportsrancho on Mar 4, 2021 20:29:48 GMT -5
Ok, simple math. Docs or mid level providers charge $300 and providers get $100. The Vedx gets rest. 10 patients equals $2000/day. Paying for overhead leaves ? FOR Profit. I’m sure you know more about all of this than I do because I’m not involved in this side of the business. But I do know just as an example in Kentucky we have one doctor and four providers and they’re all seeing patients all day long. |
|
|
|
Post by mytakeonit on Mar 4, 2021 21:28:03 GMT -5
sports - I remember that VDEX was creating branches all over the country. What is the current number of offices and in what areas?
I feel that they are doing a great job and I have always wished them well.
But, that's mytakeonit
|
|
|
|
Post by sportsrancho on Mar 4, 2021 21:43:01 GMT -5
We have one in LA. Two in New Mexico and one in Kentucky.
In Kentucky we bought the whole practice from a retiring Endo so we inherited his patients.
Also interest in New York, Texas and Florida. It’s been a little slow because of Covid people don’t want to negotiate until they can see a better picture of the environment.
|
|
|
|
Post by wsulylecoug on Mar 4, 2021 22:08:07 GMT -5
Thank you nylefty.. Right, people come to us for blood sugar control and we put them on the best program for them. Some people come for Afrezza specifically, especially with the telemedicine. Others are referred by other doctors or hospitals or they see our advertisements around town or on Facebook locally. Some have neuropathy or all kinds of different side effects from diabetes and they need guidance ,,they need someone that’s going to keep them accountable and hold their hand and change their life. They come in every week for their session and they get one on one personal attention for 45 minutes to an hour. They learn how to use a CGM, they learn about diet and ultimately we teach them how to properly dose Afrezza. Eventually we take the training wheels off and you’ve got an Afrezza user for life because believe me nothing compares!! We hire our own doctors. And train them on how to prescribe and dose Afrezza. Which is quite a bit different than their own Endo would do going by Mannkind‘s dosing instructions. Hey Sports...The "we hire our own doctors" caught my attention and was curious how difficult it was to do that. I continually read about doctor's general resistance to trying Afrezza let along advocating for it. How hard does Vdex have to search for docs that are open and maybe even eager to advocate for Afrezza use? Does the supply appear to exceed demand or vice versa? If supply is greater, how can that be used to Afrezza's advantage...or can it? |
|
|
|
Post by sportsrancho on Mar 4, 2021 22:24:29 GMT -5
I wouldn’t say it’s easy but once they get shown how Afrezza works if they’re interested they’re on board. I believe that we have no trouble filling nurse practitioner positions. Since they need to prescribe a higher dose of Afrezza they are a little leery at first ( because it is insulin:-) but soon with the right training the picture becomes clear.
|
|
|
|
Post by sportsrancho on Mar 4, 2021 22:31:30 GMT -5
|
|
|
|
Post by cretin11 on Mar 4, 2021 22:47:07 GMT -5
Thank you nylefty.. Right, people come to us for blood sugar control and we put them on the best program for them. Some people come for Afrezza specifically, especially with the telemedicine. Others are referred by other doctors or hospitals or they see our advertisements around town or on Facebook locally. Some have neuropathy or all kinds of different side effects from diabetes and they need guidance ,,they need someone that’s going to keep them accountable and hold their hand and change their life. They come in every week for their session and they get one on one personal attention for 45 minutes to an hour. They learn how to use a CGM, they learn about diet and ultimately we teach them how to properly dose Afrezza. Eventually we take the training wheels off and you’ve got an Afrezza user for life because believe me nothing compares!! We hire our own doctors. And train them on how to prescribe and dose Afrezza. Which is quite a bit different than their own Endo would do going by Mannkind‘s dosing instructions. This explains it so well. How anyone here could not be on board with this is beyond me. Even MTOI is now professing to be supportive of it, LOL. It’s simply the best model going, to get Afrezza into PWDs’ lungs. There’s no close second. In fact, there is NO other model that has worked yet. Sports, thanks for being so patient with folks here who have thrown barbs at VDEX, you are doing a good service. |
|
|
|
Post by sportsrancho on Mar 4, 2021 22:58:24 GMT -5
Thank you nylefty.. Right, people come to us for blood sugar control and we put them on the best program for them. Some people come for Afrezza specifically, especially with the telemedicine. Others are referred by other doctors or hospitals or they see our advertisements around town or on Facebook locally. Some have neuropathy or all kinds of different side effects from diabetes and they need guidance ,,they need someone that’s going to keep them accountable and hold their hand and change their life. They come in every week for their session and they get one on one personal attention for 45 minutes to an hour. They learn how to use a CGM, they learn about diet and ultimately we teach them how to properly dose Afrezza. Eventually we take the training wheels off and you’ve got an Afrezza user for life because believe me nothing compares!! We hire our own doctors. And train them on how to prescribe and dose Afrezza. Which is quite a bit different than their own Endo would do going by Mannkind‘s dosing instructions. This explains it so well. How anyone here could not be on board with this is beyond me. Even MTOI is now professing to be supportive of it, LOL. It’s simply the best model going, to get Afrezza into PWDs’ lungs. There’s no close second. In fact, there is NO other model that has worked yet. Sports, thanks for being so patient with folks here who have thrown barbs at VDEX, you are doing a good service. Thank you very much...it has not been easy, but this is why I was on board with them years ago. And so appreciative to be a part of the Vdex/Afrezza revelation. |
|
|
|
Post by prcgorman2 on Mar 5, 2021 7:06:02 GMT -5
I am appreciative although the whole HfM fiasco severely pissed me off. The fact is our TRx numbers are still anemic, VDEX or not. What I am hopeful of (and wish I could be confident of) is that VDEX is rewarded richly for their vision and perseverence once the headwinds abate that are holding both VDEX and MNKD back. What I do not assume is that the biggest headwinds are VDEX’s lack of securing special discounts, manufacturing rights, or exclusivity of sales territories. Those would no doubt help VDEX secure access to capital on better terms and perhaps greater amounts, and help them with their business plan which would in turn help Mannkind, but those are not minor concessions and given the Mannkind disastrous experience with their previous marketing agreement in which they secured a commitment for more than $1B, they can perhaps be forgiven an extra reluctance.
|
|
|
|
Post by sportsrancho on Mar 5, 2021 7:36:56 GMT -5
Vdex was here way before Mike, founded because of Al Mann. Bill and Matt P have the highest regard for each other. So yeah there were some things that pissed everybody off.
When you go through a scary time and you’re afraid Afrezza is not going to get the recognition it deserves egos abound. People fight, they disagree, but when businessmen find common ground...they get it over it and move forward.. you should too:-)
For the hundredth time we never wanted exclusive rights to territories and we don’t now, there is nothing like that on the table.
|
|
|
|
Post by sportsrancho on Mar 5, 2021 7:54:14 GMT -5
When I said it’s time for Mannkind and Vdex to work together that just means I think there’s ways we can find to help each other, studies etc. Who knows. We had to prove our model. I believe we’ve done that. We all want the same thing, the best care for diabetics and a blockbuster product. For Afrezza to get the recognition it deserves.
Vdex has found there’s so much more Afrezza can do if it’s utilized to its full capabilities.
Stay tuned:-)
|
|
|
|
Post by morfu on Mar 5, 2021 8:43:18 GMT -5
>> Very impressive. Not really! All it shows is that Afrezza (and their other technologies) works! What is missing here is data proofing the claims, that they contribute significantly to Afrezza patient numbers (the study is about 76 patients for a whole year) and at the same time their retention rate is higher than other Afrezza patients.
The report told us— Average starting HbA1c: 10.4 Average lowest HbA1c attained: 6.6 Total drop in HbA1c: 3.8 in about 104 days. That is significant. All done using Afrezza. Sure, CGMs help guide the patient, but it is the Afrezza that is doing the magic. Also something else pretty remarkable worth mentioning from the report is: While these gross numbers are impressive, perhaps more impressive is that 72% of patients attained an HbA1c of 7 or below. Majority of PWD don’t reach that level, which is set by ADA, and is actually still much too high as it is still in the red zone for microvascular damage, oxidative stress and so on. Vdex goes beyond the proven treat to failure protocols of ADA. So please tell me, why was that reported? About 10years ago Sam Finta reported similar numbers. Back then it was new and noteworthy! Now it only shows how Afrezza works, which is helping VDex. What is missing is any benefit of VDex for Mannkind. 76 patients over a year? We are getting more than 4fold that number per week!
What is the demonstrated benefit for Afrezza users to go that route? Obviously there are other ways to get Afrezza covered by insurance and use it correctly. There might be facts how VDex contributes to Afrezza, but why don´t they present them?
Any emtpy post (full of promises) seems to speak quite loudly!
|
|
|
|
Post by sportsrancho on Mar 5, 2021 9:32:09 GMT -5
76 people where the patients in the study..the more studies you do the more White Papers you write the more people see the results of those studies. Mannkind manufactures the product.
I remember three of the Mannkind reps being super excited about the first White Paper. There was even a conference call about what parts of it they could use and couldn’t use in marketing to doctors.
|
|
